open access

Vol 12, No 2 (2008)
Original paper
Published online: 2008-04-03
Get Citation

Antihypertensive treatment among 75 thousand patients in primary care settings - POZ-NAD study

Andrzej Steciwko, Andrzej Januszewicz, Grzegorz Opolski, Aleksander Prejbisz, Maciej Niewada, Agnieszka Delekta, Dagmara Pokorna-Kałwak, Agnieszka Mastalerz-Migas
Nadciśnienie tętnicze 2008;12(2):101-108.

open access

Vol 12, No 2 (2008)
Prace oryginalne
Published online: 2008-04-03

Abstract


Background It has been reported that hypertension is still inadequately controlled in the majority of patients. Recent ESH/ESC guidelines (2007) emphasize that blood pressure should be lowered below 140/90 mm Hg in all hypertensive patients and below 130/80 mm Hg in hypertensive subjects with diabetes or associated cardiovascular disease. The aim of present study was to analyze clinical characteristics of hypertensive subjects in primary care settings in a large sample of patients in Poland.
Material and methods The study included hypertensive subjects aged 18 years or more. Based on medical history and physical examination family practitioners filled questionnaires. Selected laboratory investigations were also included. The risk of diabetes was established based on Finnish diabetes risk score (FINDRISC).
Results 74 745 hypertensive subjects were included in the study (mean age 59.7±11.5 years, females 58.5%). Mean body mass index was 28.8 kg/m2. Abdominal obesity was found in almost half of the patients. In 23.1% i 6.5% patients diabetes risk based on FINDRISC score was high and very high. Mean number of antihypertensive drugs was 1.9 ± 1.0, median 2 drugs. In the studied population, 60.1% of patients received 2 or more antihypertensive drugs. 3 or more antihypertensive drugs were used in 28.5% of patients. In patients without diabetes or established cardiovascular disease target blood pressure levels were achieved in 1 of 3 patients. LDL cholesterol serum concentration of 115 mg/dl or lower was found in 35.1% of patients. In patient with diabetes or established cardiovascular disease target blood pressure levels (< 130/80 mm Hg) were achieved in 7.0% of patient. LDL cholesterol serum concentration of 100 mg/dl or lower was found in 21.7% of patients.
Conclusions In the large sample of hypertensive subjects in the primary care settings, target blood pressure levels were achieved in the minority of patients. Lower target blood pressure levels recommended by recent guidelines were achieved in less than 10% of patients with diabetes or established cardiovascular disease. The implementation of current recommendation is insufficient in primary care settings.

Abstract


Background It has been reported that hypertension is still inadequately controlled in the majority of patients. Recent ESH/ESC guidelines (2007) emphasize that blood pressure should be lowered below 140/90 mm Hg in all hypertensive patients and below 130/80 mm Hg in hypertensive subjects with diabetes or associated cardiovascular disease. The aim of present study was to analyze clinical characteristics of hypertensive subjects in primary care settings in a large sample of patients in Poland.
Material and methods The study included hypertensive subjects aged 18 years or more. Based on medical history and physical examination family practitioners filled questionnaires. Selected laboratory investigations were also included. The risk of diabetes was established based on Finnish diabetes risk score (FINDRISC).
Results 74 745 hypertensive subjects were included in the study (mean age 59.7±11.5 years, females 58.5%). Mean body mass index was 28.8 kg/m2. Abdominal obesity was found in almost half of the patients. In 23.1% i 6.5% patients diabetes risk based on FINDRISC score was high and very high. Mean number of antihypertensive drugs was 1.9 ± 1.0, median 2 drugs. In the studied population, 60.1% of patients received 2 or more antihypertensive drugs. 3 or more antihypertensive drugs were used in 28.5% of patients. In patients without diabetes or established cardiovascular disease target blood pressure levels were achieved in 1 of 3 patients. LDL cholesterol serum concentration of 115 mg/dl or lower was found in 35.1% of patients. In patient with diabetes or established cardiovascular disease target blood pressure levels (< 130/80 mm Hg) were achieved in 7.0% of patient. LDL cholesterol serum concentration of 100 mg/dl or lower was found in 21.7% of patients.
Conclusions In the large sample of hypertensive subjects in the primary care settings, target blood pressure levels were achieved in the minority of patients. Lower target blood pressure levels recommended by recent guidelines were achieved in less than 10% of patients with diabetes or established cardiovascular disease. The implementation of current recommendation is insufficient in primary care settings.
Get Citation

Keywords

hypertension; target values; antihypertensive treatment; primary care settings

About this article
Title

Antihypertensive treatment among 75 thousand patients in primary care settings - POZ-NAD study

Journal

Arterial Hypertension

Issue

Vol 12, No 2 (2008)

Article type

Original paper

Pages

101-108

Published online

2008-04-03

Page views

830

Article views/downloads

2372

Bibliographic record

Nadciśnienie tętnicze 2008;12(2):101-108.

Keywords

hypertension
target values
antihypertensive treatment
primary care settings

Authors

Andrzej Steciwko
Andrzej Januszewicz
Grzegorz Opolski
Aleksander Prejbisz
Maciej Niewada
Agnieszka Delekta
Dagmara Pokorna-Kałwak
Agnieszka Mastalerz-Migas

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl